CULTRERA, R. Place in therapy of dalbavancin to treat Gram-positive infections in antimicrobial resistance era: an overview. Global and Regional Health Technology Assessment, [S. l.], v. 11, n. Suppl. 2, p. 1–4, 2024. DOI: 10.33393/grhta.2024.3108. Disponível em: https://journals.aboutscience.eu/index.php/grhta/article/view/3108. Acesso em: 12 sep. 2024.